RBC Capital Positive on Alnylam Pharmaceuticals (ALNY): 'HELIOS-B Hits Convincingly Across the Board, Materially Exceeding Expectations'
Go back to RBC Capital Positive on Alnylam Pharmaceuticals (ALNY): 'HELIOS-B Hits Convincingly Across the Board, Materially Exceeding Expectations'| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 282.85 -6.54 (2.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.39 | 52 Week High | $109.10 | |||
| Open | $288.96 | 52 Week Low | $31.38 | |||
| Day High | $291.28 | P/E | N/A | |||
| Day Low | $281.77 | EPS | $-1.45 | |||
| Volume | 1,420,051 | |||||
